Replies to post #1007 on Trevena Inc (TRVN)

[Biotech Investr]

I have a similar theory, cbb.

@SuperDuperInvst @khammaker9 Insiders had been selling $TRVN prior to FDA decision. Perhaps the approval surprised them? If so, a secondary would allow them to get back in at pre-approval share price. https://t.co/6lXJKydJcY

— Peaceinmiddleeast (@biotechinvestr) August 11, 2020